Pierre Clerson

6.7k total citations · 1 hit paper
107 papers, 4.2k citations indexed

About

Pierre Clerson is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Pierre Clerson has authored 107 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 28 papers in Pulmonary and Respiratory Medicine and 25 papers in Pathology and Forensic Medicine. Recurrent topics in Pierre Clerson's work include Systemic Sclerosis and Related Diseases (21 papers), Pulmonary Hypertension Research and Treatments (19 papers) and Blood Pressure and Hypertension Studies (17 papers). Pierre Clerson is often cited by papers focused on Systemic Sclerosis and Related Diseases (21 papers), Pulmonary Hypertension Research and Treatments (19 papers) and Blood Pressure and Hypertension Studies (17 papers). Pierre Clerson collaborates with scholars based in France, United States and Switzerland. Pierre Clerson's co-authors include É. Hachulla, Virginie Gressin, David Launay, Marc Humbert, Gérald Simonneau, Pascal de Groote, Olivier Sitbon, Loı̈c Guillevin, Élisabeth Diot and Patrick Carpentier and has published in prestigious journals such as New England Journal of Medicine, Blood and PLoS ONE.

In The Last Decade

Pierre Clerson

103 papers receiving 4.1k citations

Hit Papers

Early detection of pulmonary arterial hypertension in sys... 2005 2026 2012 2019 2005 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study
    2005 520 citations É. Hachulla, Virginie Gressin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Clerson France 32 1.8k 1.5k 1.2k 605 556 107 4.2k
Reda E. Girgis United States 45 5.9k 3.2× 1.1k 0.8× 3.4k 2.8× 657 1.1× 1.8k 3.3× 136 7.7k
Carmine Dario Vizza Italy 34 3.8k 2.1× 299 0.2× 3.2k 2.6× 495 0.8× 686 1.2× 214 4.9k
Lorenzo Cavagna Italy 28 671 0.4× 496 0.3× 149 0.1× 118 0.2× 265 0.5× 119 2.2k
M Brozović United Kingdom 30 1.4k 0.8× 191 0.1× 869 0.7× 1.2k 2.0× 623 1.1× 74 4.4k
Waleed Ghanima Norway 36 580 0.3× 523 0.3× 1.1k 0.9× 635 1.0× 1.5k 2.7× 208 5.3k
Maurizio Salvadori Italy 33 769 0.4× 242 0.2× 637 0.5× 121 0.2× 1.2k 2.2× 185 4.8k
Ross Baker Australia 33 512 0.3× 335 0.2× 2.3k 1.9× 475 0.8× 1.2k 2.1× 136 6.0k
Casper Franssen Netherlands 31 1.1k 0.6× 237 0.2× 536 0.4× 325 0.5× 838 1.5× 144 3.7k
Evans R. Fernández Pérez United States 31 3.6k 2.0× 569 0.4× 254 0.2× 83 0.1× 285 0.5× 71 4.5k
Emília Inoue Sato Brazil 33 453 0.2× 689 0.5× 174 0.1× 186 0.3× 265 0.5× 125 3.2k

Countries citing papers authored by Pierre Clerson

Since Specialization
Citations

This map shows the geographic impact of Pierre Clerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Clerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Clerson more than expected).

Fields of papers citing papers by Pierre Clerson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Clerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Clerson. The network helps show where Pierre Clerson may publish in the future.

Co-authorship network of co-authors of Pierre Clerson

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Clerson. A scholar is included among the top collaborators of Pierre Clerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Clerson. Pierre Clerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stéphan, François, Loriane Gutermann, Sarah Djabarouti, et al.. (2023). Real‐World Experience with a Human Fibrinogen Concentrate: Clinical Data from Adult and Pediatric Patients Requiring Fibrinogen for Bleeding Control and Prevention. The Journal of Clinical Pharmacology. 63(11). 1186–1196.
2.
Viallard, Jean‐François, Sylvain Choquet, Bruno Royer, et al.. (2018). The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departments. Hematology. 24(1). 173–182. 19 indexed citations
3.
4.
Launay, David, David Montani, Paul M. Hassoun, et al.. (2018). Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis. PLoS ONE. 13(5). e0197112–e0197112. 45 indexed citations
5.
Bardin, Thomas, et al.. (2017). THU0463 Epidemiology of gout and hyperuricemia in new caledonia. Annals of the Rheumatic Diseases. 76. 382–383. 2 indexed citations
6.
7.
Amédro, Pascal, Adeline Basquin, Virginie Gressin, et al.. (2014). 0238: Quality of life of patients with pulmonary arterial hypertension associated with congenital heart disease: the multicenter cross-sectional Achille study. European Respiratory Journal. 44(1). 92–93. 1 indexed citations
8.
Solal, Alain Cohen, et al.. (2012). Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: The FUTURE survey. Archives of cardiovascular diseases. 105(6-7). 355–365. 44 indexed citations
9.
Launay, David, Marc Humbert, A. Bérezné, et al.. (2011). Clinical Characteristics and Survival in Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease. CHEST Journal. 140(4). 1016–1024. 68 indexed citations
10.
Hachulla, É., David Launay, A. Yaïci, et al.. (2010). Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome. Lara D. Veeken. 49(5). 940–944. 46 indexed citations
11.
Solal, Alain Cohen, et al.. (2010). 092 “Grey Zone” of 40-50% ejection fraction in ambulatory patient with Heart Failure. Who are these patients? Lessons from the DEVENIR study. Archives of Cardiovascular Diseases Supplements. 2(1). 31–31. 2 indexed citations
12.
Hachulla, É., David Launay, Pierre Clerson, & Marc Humbert. (2010). Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis?. CHEST Journal. 138(2). 462–463. 5 indexed citations
13.
Groote, Pascal de, Richard Isnard, Pierre Clerson, et al.. (2009). Improvement in the Management of Chronic Heart Failure Since the Publication of the Updated Guidelines of the European Society of Cardiology. European Journal of Heart Failure. 11(1). 85–91. 44 indexed citations
14.
Kemoun, G., et al.. (2008). Réhabilitation respiratoire: résultats à un an sur la tolérance à l'effort et la qualité de vie. Revue des Maladies Respiratoires. 17(4). 849–855. 1 indexed citations
15.
Bobrie, Guillaume, Pierre Clerson, Joël Ménard, et al.. (2008). Masked hypertension: a systematic review. Journal of Hypertension. 26(9). 1715–1725. 181 indexed citations
16.
Sitbon, Olivier, Caroline Lascoux‐Combe, Jean‐François Delfraissy, et al.. (2007). Prevalence of HIV-Related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era. American Journal of Respiratory and Critical Care Medicine. 177(1). 108–113. 322 indexed citations
17.
Groote, Pascal de, Richard Isnard, Pierre Clerson, et al.. (2007). Is the Gap Between Guidelines and Clinical Practice in Heart Failure Treatment Being Filled? Insights from the IMPACT RECO Survey. European Journal of Heart Failure. 9(12). 1205–1211. 97 indexed citations
18.
Mounier‐Véhier, Claire, et al.. (2002). Randomized, comparative, double‐blind study of amlodipine vs. nicardipine as a treatment of isolated systolic hypertension in the elderly. Fundamental and Clinical Pharmacology. 16(6). 537–544. 4 indexed citations
19.
Dréno, Brigitte, Ferruccio Poli, N. Auffret, et al.. (2000). [Descriptive epidemiological study of acne on scholar pupils in France during autumn 1996].. PubMed. 127(3). 273–8. 30 indexed citations
20.
Goffinet, François, et al.. (1999). [National survey on the use of induced labor by obstetricians. Study Group on Induced Labor].. PubMed. 28(4). 319–29. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reda E. Girgis Breakdown of academic impact, for papers by Carmine Dario Vizza Breakdown of academic impact, for papers by Lorenzo Cavagna Breakdown of academic impact, for papers by M Brozović Breakdown of academic impact, for papers by Waleed Ghanima Breakdown of academic impact, for papers by Maurizio Salvadori Breakdown of academic impact, for papers by Ross Baker Breakdown of academic impact, for papers by Casper Franssen Breakdown of academic impact, for papers by Evans R. Fernández Pérez Breakdown of academic impact, for papers by Emília Inoue Sato
Rankless by CCL
2026